Hasil Pencarian - Hanny Al‐Samkari

Perbaiki Hasil
  1. 1
    Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extension

    Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extension oleh Hanny Al‐Samkari, Srikanth Nagalla

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Adenovirus-associated thrombosis and thrombocytopenia: an emerging anti-PF4 disorder

    Adenovirus-associated thrombosis and thrombocytopenia: an emerging anti-PF4 disorder oleh Andrew B. Song, Hanny Al-Samkari

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Romiplostim for PARP inhibitor-induced thrombocytopenia in solid tumor malignancies

    Romiplostim for PARP inhibitor-induced thrombocytopenia in solid tumor malignancies oleh Abraham Z. Cheloff, Hanny Al‐Samkari

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia

    Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia oleh Hanny Al-Samkari, David J. Kuter

    Diterbitkan 2019-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy

    Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy oleh Hanny Al-Samkari, Jean M. Connors

    Diterbitkan 2019-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias

    Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias oleh Hanny Al-Samkari, Eduard J. van Beers

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Infections and vaccination in hereditary hemorrhagic telangiectasia: microbiological evidence-based considerations

    Infections and vaccination in hereditary hemorrhagic telangiectasia: microbiological evidence-based considerations oleh Hanny Al-Samkari, Athena Kritharis, David J. Kuter

    Diterbitkan 2018-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Recognition of thrombotic risk of thrombocytosis in iron deficiency

    Recognition of thrombotic risk of thrombocytosis in iron deficiency oleh Hanny Al-Samkari, Craig M. Kessler, Michael Auerbach

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist’s perspective

    Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist’s perspective oleh Athena Kritharis, Hanny Al-Samkari, David J Kuter

    Diterbitkan 2018-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    The role of romiplostim for pediatric patients with immune thrombocytopenia

    The role of romiplostim for pediatric patients with immune thrombocytopenia oleh Hanny Al-Samkari, Rachael F. Grace, David J. Kuter

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Serum complement levels in immune thrombocytopenia: Characterization and relation to clinical features

    Serum complement levels in immune thrombocytopenia: Characterization and relation to clinical features oleh Abraham Z. Cheloff, David J. Kuter, Hanny Al‐Samkari

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significance

    Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significance oleh Marie A. Hollenhorst, Hanny Al-Samkari, David J. Kuter

    Diterbitkan 2019-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors

    The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors oleh Hanny Al-Samkari, Ariela L. Marshall, Katayoon Goodarzi, David J Kuter

    Diterbitkan 2018-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Romiplostim in chemotherapy‐induced thrombocytopenia: A review of the literature

    Romiplostim in chemotherapy‐induced thrombocytopenia: A review of the literature oleh Gerald A. Soff, Hanny Al‐Samkari, Avi Leader, Melissa Eisen, Hossam Saad

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Response to rituximab in children and adults with immune thrombocytopenia (ITP)

    Response to rituximab in children and adults with immune thrombocytopenia (ITP) oleh Emily M. Harris, Kirsty Hillier, Hanny Al‐Samkari, Laura Berbert, Rachael F. Grace

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers

    Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers oleh Hanny Al-Samkari, Hasan A. Albitar, Scott E. Olitsky, Marianne S. Clancy, Vivek N. Iyer

    Diterbitkan 2019-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    P1477: MITAPIVAT EFFICACY IN ADULTS WITH PYRUVATE KINASE DEFICIENCY AND BASELINE HEMOGLOBIN LEVELS >10 G/DL

    P1477: MITAPIVAT EFFICACY IN ADULTS WITH PYRUVATE KINASE DEFICIENCY AND BASELINE HEMOGLOBIN LEVELS >10 G/DL oleh Rachael F. Grace, Janet Kwiatkowski, Eduard van Beers, Feng Tai, Bryan Mcgee, Hanny Al-Samkari

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies

    A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies oleh Hanny Al-Samkari, Aric D. Parnes, Katayoon Goodarzi, James I. Weitzman, Jean M. Connors, David J. Kuter

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis

    The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis oleh Ingrid Lindquist, Sven R. Olson, Ang Li, Hanny Al‐Samkari, Janice H. Jou, Owen J. T. McCarty, Joseph J. Shatzel

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Mortality among US veterans with a physician-documented diagnosis of pyruvate kinase deficiency

    Mortality among US veterans with a physician-documented diagnosis of pyruvate kinase deficiency oleh Erin Zagadailov, Hanny Al-Samkari, Audra N. Boscoe, Bryan McGee, Sherry Shi, Dendy Macaulay, Lizheng Shi, Viviana Garcia-Horton

    Diterbitkan 2024-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: